Masimo Corporation appears in the linked FDA record as the applicant for K260676, a Traditional 510(k) for Radius VSM and Accessories under product code MHX. The filing was received on March 2, 2026, and decided on October 14, 2026, with decision code SESE, described as Substantially Equivalent. The applicant address in the filing is 52 Discovery, Irvine, California. Masimo's product page presents Radius VSM as a wearable, scalable, continuous vital signs monitor spanning general floor through high-acuity care areas. [1][3]
The K260676 clearance and its scope
The linked FDA record lists K260676 as a Traditional 510(k) with a third-party review flag of N and a review advisory committee of Cardiovascular. The associated openFDA device entry names the device as Monitor, Physiological, Patient (With Arrhythmia Detection Or Alarms), device class 2, regulation number 870.1025, and medical specialty Cardiovascular. The decision description is Substantially Equivalent, and the record indicates a summary is available. [1]
The FDA 510(k) database page for K260676 is the public lookup entry for the same notification. It presents the standard premarket notification database navigation, including links to DeNovo, Registration & Listing, Adverse Events, Recalls and PMA resources, but the supplied excerpt does not add device-specific detail beyond identifying the record. [2]
How Masimo describes Radius VSM
Masimo's Radius VSM product page describes the device as a wearable, scalable, continuous vital signs monitor, positioned from the general floor to high-acuity care areas. The same page places Radius VSM within a product navigation that also lists Root, Radical, Rad and Radius, indicating a family of monitoring offerings rather than a single standalone device. [3]
Masimo's technical documentation site lists Radius VSM under its device documents, with a table of part IDs, descriptions, languages, order numbers, revision dates and safety flags, and notes that manuals are subject to change with the current version on the site. The operator's manual describes Radius VSM as a patient-worn vital signs monitor and states that general knowledge of pulse oximetry and understanding of the device's features are prerequisites for proper use. [5][6]
Earlier filing context and corporate attribution
A May 29, 2025 FDA substantial equivalence determination letter for K250757, also titled Radius VSM and Accessories, is addressed to Masimo Corporation at 52 Discovery, Irvine, California, and lists regulation number 21 CFR 870.1025, regulatory class II, and product codes including MHX, BZQ, DQA, DPS, DPZ, DRT, DSJ, DXN, FLL, KMI, DSI, DQK and DXQ. That letter documents an earlier clearance for the same trade name, separate from the K260676 record in the supplied portfolio sample. [4]
A Masimo press release dated October 17, 2026, describes Masimo as a Danaher company and a specialty diagnostics solutions innovator of pulse oximetry and other patient monitoring solutions, and announces an FDA clearance for its smartSET pulse oximetry platform with atrial fibrillation detection and previously cleared AI-enabled opioid-induced respiratory depression detection. The release identifies the media contact as affiliated with Danaher, Diagnostics. [7]




